Disclosure of Funding Sources and Conflicts of Interest in Phase III Surgical Trials: Survey of Ten General Surgery Journals

Thompson DF (1993) Understanding financial conflicts of interest. N Engl J Med 329:573–576 Mack MJ, Sade RM (2009) Relations between cardiothoracic surgeons and industry. Ann Thorac Surg 87:1334–1336 Bekelman JE, Li Y, Gross CP (2003) Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 289:454–465 Bodenheimer T (2000) Uneasy alliance: clinical investigators and the pharmaceutical industry. N Engl J Med 342:1539–1544 Moher D, Hopewell S, Schulz KF et al (2010) CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 340:c869 Drazen JM, Van der Weyden MB, Sahni P et al (2010) Uniform format for disclosure of competing interests in ICMJE journals. JAMA 303:75–76 Hussain A, Smith R (2001) Declaring financial competing interests: survey of five general medical journals. BMJ 323:263–264 International Committee of Medical Journal Editors (2012) Journals that have requested inclusion on the list of publications that follow the ICMJE’s Uniform Requirements For Manuscripts Submitted to Biomedical Journals. http://www.icmje.org/jrnlist.html. Accessed 25 Jan 2012 Gayral F, Campion JP, Regimbeau JM et al (2009) Randomized, placebo-controlled, double-blind study of the efficacy of lanreotide 30 mg PR in the treatment of pancreatic and enterocutaneous fistulae. Ann Surg 250:872–877 Wassenaar E, Schoenmaeckers E, Raymakers J et al (2010) Mesh-fixation method and pain and quality of life after laparoscopic ventral or incisional hernia repair: a randomized trial of three fixation techniques. Surg Endosc 24:1296–1302 Yellin AE, Johnson J, Higareda I et al (2007) Ertapenem or ticarcillin/clavulanate for the treatment of intra-abdominal infections or acute pelvic infections in pediatric patients. Am J Surg 194:367–374 Malangoni MA, Song J, Herrington J et al (2006) Randomized controlled trial of moxifloxacin compared with piperacillin–tazobactam and amoxicillin–clavulanate for the treatment of complicated intra-abdominal infections. Ann Surg 244:204–211 Dellinger EP, Tellado JM, Soto NE et al (2007) Early antibiotic treatment for severe acute necrotizing pancreatitis: a randomized, double-blind, placebo-controlled study. Ann Surg 245:674–683 Agnelli G, Bergqvist D, Cohen AT et al (2005) Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery. Br J Surg 92:1212–1220 Cookson R, Flood C, Koo B et al (2005) Short-term cost effectiveness and long-term cost analysis comparing laparoscopic Nissen fundoplication with proton-pump inhibitor maintenance for gastro-oesophageal reflux disease. Br J Surg 92:700–706 Chemla ES, Morsy M (2009) Randomized clinical trial comparing decellularized bovine ureter with expanded polytetrafluoroethylene for vascular access. Br J Surg 96:34–39 Lerut J, Mathys J, Verbaandert C et al (2008) Tacrolimus monotherapy in liver transplantation: one-year results of a prospective, randomized, double-blind, placebo-controlled study. Ann Surg 248:956–967 Shantha Kumara HM, Kirman I, Feingold D et al (2009) Perioperative GMCSF limits the proangiogenic plasma protein changes associated with colorectal cancer resection. Eur J Surg Oncol 35:295–301 Woodle ES, First MR, Pirsch J et al (2008) A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Ann Surg 248:564–577 Gross CP, Gupta AR, Krumholz HM (2003) Disclosure of financial competing interests in randomised controlled trials: cross sectional review. BMJ 326(7388):526–527 Riechelmann RP, Wang L, O’Carroll A et al (2007) Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology. J Clin Oncol 25:4642–4647 Tuech JJ, Moutel G, Pessaux P et al (2005) Disclosure of competing financial interests and role of sponsors in phase III cancer trials. Eur J Cancer 41:2237–2240 Als-Nielsen B, Chen W, Gluud C et al (2003) Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? JAMA 290:921–928 Chan AW, Altman DG (2005) Epidemiology and reporting of randomised trials published in PubMed journals. Lancet 365:1159–1162 Klitzman R, Chin LJ, Rifai-Bishjawish H et al (2010) Disclosures of funding sources and conflicts of interest in published HIV/AIDS research conducted in developing countries. J Med Ethics 36:505–510 Weinfurt KP, Seils DM, Tzeng JP et al (2008) Consistency of financial interest disclosures in the biomedical literature: the case of coronary stents. PLoS One 3:e2128 Chaudhry S, Schroter S, Smith R et al (2002) Does declaration of competing interests affect readers’ perceptions? A randomised trial. BMJ 325:1391–1392 Schroter S, Morris J, Chaudhry S et al (2004) Does the type of competing interest statement affect readers’ perceptions of the credibility of research? Randomised trial. BMJ 328:742–743 Kjaergard LL, Als-Nielsen B (2002) Association between competing interests and authors’ conclusions: epidemiological study of randomised clinical trials published in the BMJ. BMJ 325:249 Bhandari M, Busse JW, Jackowski D et al (2004) Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. Can Med Assoc J 170:477–490 Friedman LS, Richter ED (2004) Relationship between conflicts of interest and research results. J Gen Intern Med 19:51–56 Jagsi R, Sheets N, Jankovic A et al (2009) Frequency nature, effects, and correlates of conflicts of interest in published clinical cancer research. Cancer 115:2783–2791 Bero L, Oostvogel F, Bacchetti P et al (2007) Factors associated with findings of published trials of drug–drug comparisons: why some statins appear more efficacious than others. PLoS Med 4:e184 Sismondo S (2008) Pharmaceutical company funding and its consequences: a qualitative systematic review. Contemp Clin Trials 29:109–113 Lexchin J, Bero LA, Djulbegovic B et al (2003) Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 326:1167–1170 Clifford TJ, Barrowman NJ, Moher D (2002) Funding source, trial outcome and reporting quality: are they related? Results of a pilot study. BMC Health Serv Res 2:18 Stossel TP (2008) A biopsy of financial conflicts of interest in medicine. Surgery 143:193–198 Duvall DG (2006) Conflict of interest or ideological divide: the need for ongoing collaboration between physicians and industry. Curr Med Res Opin 22:1807–1812 Khan SN, Mermer M Myers E et al (2008) The roles of funding source, clinical trial outcome, and quality of reporting in orthopedic surgery literature. Am J Orthop 37:E205–12; discussion E12 Ross JS, Hill KP, Egilman DS et al (2008) Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation. JAMA 299:1800–1812 Bhattacharyya N, Lin HW (2009) Prevalence and reliability of self-reported authorship disclosures in otolaryngology-head and neck surgery. Otolaryngol Head Neck Surg 141:311–315 Okike K, Kocher MS, Wei EX et al (2009) Accuracy of conflict-of-interest disclosures reported by physicians. N Engl J Med 361:1466–1474